Sedana Medical AB (publ) (STO:SEDANA)

Market Cap	978.47M -20.2%
Revenue (ttm)	196.15M +4.7%
Net Income	-39.52M
EPS	-0.40
Shares Out	99.34M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	26,695
Average Volume	89,105
Open	9.98
Previous Close	9.85
Day's Range	9.83 - 9.98
52-Week Range	8.20 - 18.32
Beta	0.80
RSI	54.46
Earnings Date	Jul 17, 2026

About Sedana Medical AB

Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Spain, Germany, and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-S, which are disposable medical devices that enable the administration of volatile anaesthetics; Sedaconda Syringe, a 50/60ml syringe; Sedaconda ACD starter kit; Sedaconda (Isoflurane) for maintenance of sedation in intubated or tracheostomised mechanically ventilated adult and paediatric patients from 3 y...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 116
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: SEDANA

Financial Performance

In 2025, Sedana Medical AB's revenue was 200.23 million, an increase of 12.01% compared to the previous year's 178.75 million. Losses were -59.24 million, 455.0% more than in 2024.